Triple-Negative Breast Cancer

William D. Foulkes(McGill University Health Centre), Ian E. Smith(Royal Marsden Hospital), Jorge S. Reis‐Filho(Breast Cancer Research Foundation)
New England Journal of Medicine
November 10, 2010
Cited by 4,155

Abstract

Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.


Related Papers

No related papers found

Powered by citation graph analysis